{"id":261775,"date":"2018-09-06T10:21:20","date_gmt":"2018-09-06T10:21:20","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=261775"},"modified":"2018-09-06T10:21:20","modified_gmt":"2018-09-06T10:21:20","slug":"radiopharmaceuticals-market-2018-global-share-trend-and-opportunities-forecast-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/radiopharmaceuticals-market-2018-global-share-trend-and-opportunities-forecast-to-2023_261775.html","title":{"rendered":"Radiopharmaceuticals Market 2018 Global Share, Trend And Opportunities Forecast To 2023"},"content":{"rendered":"
\n
“Radiopharmaceuticals”<\/div>\n<\/div>\n
Wiseguyreports.Com Adds \u201cRadiopharmaceuticals -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023\u201d To Its Research Database<\/p>\n<\/div>\n

Radiopharmaceuticals <\/strong>Industry<\/strong><\/a><\/p>\n

Description<\/strong><\/p>\n

Radiopharmaceuticals are medicinal formulations that contain radioisotopes. They are composed of a radioisotope and a carrier molecule and are generally molded according to the physiological function of the targeted organ. After administration, the radioisotope emits gamma radiation, which is used for either therapeutic or diagnostic purposes. In recent years, the market for diagnostic radiopharmaceuticals has shown growth due to the increasing incidence of cancer and neurological and cardiac diseases and the development of better imaging techniques for conditions such as Alzheimer’s disease. Therapeutic radiopharmaceuticals account for a small proportion of the global radiopharmaceuticals market. However, the market for therapeutic <\/p>\n

radiop-harmaceuticals is expected to experience strong growth in the coming years due to increased demand.<\/p>\n

R&D spending, along with increasing competition, expiration of related patent and new technologies, are giving a new direction to the market. Technology advancements, new product launches and changing lifestyles will influence future market growth. This study discusses how these factors will affect the market.<\/p>\n

Companies’ acquisition strategies and collaborations are also covered in this report. Further, the report discusses the strengths and weaknesses of each 
radiopharmaceuticals type in light of new technologies, growing competition and changing customer needs.<\/p>\n

SCOPE OF THE STUDY<\/strong><\/p>\n

This report focuses on the global market for radiopharmaceutical products. Radiopharmaceuticals provide actual mapping of the physiological functions and metabolic activity of organs. They provide highly specific information on organ function and dysfunction. Radiopharmaceuticals can also be used in radiotherapy to destroy dysfunctional cells.<\/p>\n

In this report, BCC Research analyzes each global market in terms of applications, regulatory environment, new products and advancements, market projections and market shares. The geographical regions covered in the report are North America and Europe and an emerging markets category. The emerging markets category covers countries that include India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand and Canada.<\/p>\n

This report also includes an analysis of relevant patent and comprehensive profiles of leading companies in the radiopharmaceuticals industry. Some of the major global players in the radiopharmaceuticals industry are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Bayer AG (Bayer HealthCare Pharmaceuticals Inc.), Bracco S.p.A. (Bracco Imaging S.p.A.), Cardinal Health Inc., Eli Lilly and Co., Fujifilm RI Pharma Co. Ltd. (Fujifilm Corp.), General Electric Co. (GE Healthcare), Jubilant Life Sciences (Jubilant DraxImage Inc.), Lantheus Holdings Inc. (Lantheus Medical Imaging Inc.), Mallinckrodt PLC, Navidea Biopharmaceuticals Inc., Noridon Inc., Piramal Enterprises Ltd. (Piramal Imaging SA), Siemens AG (Siemens PETNET Solutions Inc.) and Triad Isotopes Inc.<\/p>\n

Request for Sample Report @ https:\/\/www.wiseguyreports.com\/sample-request\/3375388-radiopharmaceuticals-technologies-and-global-markets<\/a><\/strong><\/p>\n

Report Scope:<\/strong><\/p>\n

This report focuses on the global market for radiopharmaceutical products. Radiopharmaceuticals provide actual mapping of the physiological functions and metabolic activity of organs. They provide highly specific information on organ function and dysfunction. Radiopharmaceuticals can also be used in radiotherapy to destroy dysfunctional cells.<\/p>\n

In this report, BCC Research analyzes each global market in terms of applications, regulatory environment, new products and advancements, market projections and market shares. The geographical regions covered in the report are North America and Europe and an emerging markets category. The emerging markets category covers countries that include India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand and Canada.<\/p>\n

This report also includes an analysis of relevant patent and comprehensive profiles of leading companies in the radiopharmaceuticals industry. Some of the major global players in the radiopharmaceuticals industry are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Bayer AG (Bayer HealthCare Pharmaceuticals Inc.), Bracco S.p.A. (Bracco Imaging S.p.A.), Cardinal Health Inc., Eli Lilly and Co., Fujifilm RI Pharma Co. Ltd. (Fujifilm Corp.), General Electric Co. (GE Healthcare), Jubilant Life Sciences (Jubilant DraxImage Inc.), Lantheus Holdings Inc. (Lantheus Medical Imaging Inc.), Mallinckrodt PLC, Navidea Biopharmaceuticals Inc., Noridon Inc., Piramal Enterprises Ltd. (Piramal Imaging SA), Siemens AG (Siemens PETNET Solutions Inc.) and Triad Isotopes Inc.<\/p>\n

Report Includes:<\/strong><\/p>\n

– An overview of the global market for radiopharmaceuticals and related technologies. 
– Analyses of global market trends, with data from 2014 and 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021. 
– Information on how radiopharmaceuticals are used to diagnose cancer, tumors, brain diseases, bone diseases, bone marrow diseases, colorectal disease, kidney diseases, liver diseases, lung diseases, and many others. 
– Details concerning the regulatory environment and the impacts of government on the market. 
– Analysis of the market’s dynamics, specifically growth drivers, restraints, and opportunities 
– Profiles of leading companies in the industry.<\/p>\n

 <\/p>\n

Table of Contents <\/strong><\/p>\n

Chapter 1 INTRODUCTION 
STUDY OBJECTIVES 
REASONS FOR DOING THIS STUDY 
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE 
SCOPE OF THE STUDY 
METHODOLOGY 
INFORMATION SOURCES 
ANALYSTS’ CREDENTIALS 
RELATED BCC RESEARCH REPORTS 
BCC RESEARCH WEBSITE 
DISCLAIMER 
Chapter 2 EXECUTIVE SUMMARY 
Chapter 3 OVERVIEW 
USES OF RADIOPHARMACEUTICALS 
DIAGNOSTIC IMAGING 
IN VIVO FUNCTION 
IN VITRO STUDIES 
THERAPEUTIC APPLICATIONS 
DEFINITIONS 
NUCLIDE 
ISOTOPE 
RADIATION 
RADIOACTIVITY 
ALPHA PARTICLES 
BETA PARTICLES 
GAMMA RAY 
RADIOACTIVE DECAY 
ISOMERIC TRANSITION 
RADIOISOTOPE 
RADIOPHARMACEUTICAL PRECURSOR 
SPECIFIC ACTIVITY 
LINEAR ENERGY TRANSFER 
NEGATRON 
POSITRON 
TRANSMUTATION 
HALF-LIFE 
NUCLEAR MEDICINE 
RADIOPHARMACY 
PHARMACOKINETICS 
MYELOSUPPRESSION 
CRITICAL ORGAN 
HISTORY AND BACKGROUND 
ORIGIN OF RADIONUCLIDES 
TYPES OF RADIONUCLIDES 
METHODS OF PRODUCING RADIONUCLIDES 
RADIONUCLIDES BY PRODUCTION TYPE 
RADIONUCLIDE GENERATORS 
COMMONLY USED RADIONUCLIDES IN MEDICINE 
TECHNETIUM-99M 
IODINE-123 
IODINE-131 
FLUORINE-18 
INDIUM-111 
THALLIUM-201 
GALLIUM-67 
PREPARATION OF RADIOPHARMACEUTICALS 
RADIOPHARMACEUTICAL PREPARATION KITS 
APPLICATIONS OF RADIOPHARMACEUTICALS 
DIAGNOSTIC RADIOPHARMACEUTICALS 
TYPES OF DIAGNOSTIC RADIOPHARMACEUTICALS 
THERAPEUTIC RADIOPHARMACEUTICALS 
THERANOSTIC AGENTS 
ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS <\/p>\n

Leave a Query @ https:\/\/www.wiseguyreports.com\/check-discount\/3375388-radiopharmaceuticals-technologies-and-global-markets<\/a><\/strong><\/p>\n

Chapter 4 REGULATORY ASPECTS <\/strong>
NEW DRUG APPROVALS AND APPLICATIONS 
INVESTIGATIONAL NEW DRUG 
NEW DRUG APPLICATION 
ABBREVIATED NEW DRUG APPLICATION 
APPROVALS FOR RADIONUCLIDE BRACHYTHERAPY SOURCES 
PREMARKET APPROVAL 
PREMARKET NOTIFICATION 510(K) 
SAFETY ALERTS 
ADVERSE EVENT REPORTING 
DRUG SHORTAGES 
Chapter 5 NEW DEVELOPMENTS 
PIPELINE PRODUCTS 
OTHER SIGNIFICANT NEW DEVELOPMENTS IN RADIOPHARMACEUTICALS 
GALLIUM-68 PET\/CT SCANS 
Chapter 6 MARKET ANALYSIS 
MARKET BY RADIOPHARMACEUTICAL TYPE 
MARKET OVERVIEW 
MARKET REVENUE 
MARKET SHARES 
DIAGNOSTIC RADIOPHARMACEUTICALS 
THERAPEUTIC RADIOPHARMACEUTICALS 
DIAGNOSTIC RADIOPHARMACEUTICALS MARKET BY REGION 
MARKET OVERVIEW 
MARKET REVENUE 
MARKET SHARES 
THERAPEUTIC RADIOPHARMACEUTICALS MARKET BY REGION 
MARKET OVERVIEW 
MARKET REVENUE 
MARKET SHARES 
RADIOPHARMACEUTICALS MARKET BY PRODUCTION METHOD 
PARTICLE ACCELERATORS (CYCLOTRONS) 
NUCLEAR REACTORS 
RADIONUCLIDE GENERATORS 
MARKET OVERVIEW 
MARKET REVENUE 
MARKET SHARES 
Chapter 7 INDUSTRY STRUCTURE 
DIAGNOSTIC RADIOPHARMACEUTICALS 
PET RADIOPHARMACEUTICALS 
SPECT RADIOPHARMACEUTICALS 
OTHER DIAGNOSTIC RADIOPHARMACEUTICALS 
THERAPEUTIC RADIOPHARMACEUTICALS 
MARKET LEADERS 
MARKET SHARES 
Chapter 8 PATENT ANALYSIS 
PATENTS BY YEAR 
PATENTS BY TYPE OF RADIONUCLIDE 
PATENTS BY COMPANY 
PATENTS BY COUNTRY 
PATENTS BY ASSIGNEE TYPE 
Chapter 9 CURRENT SITUATION 
FACTORS AFFECTING THE RADIOPHARMACEUTICALS MARKET 
DRIVERS OF THE RADIOPHARMACEUTICALS MARKET 
RESTRAINTS AND CHALLENGES OF THE MARKET 
COLLABORATIONS, MERGERS AND ACQUISITIONS 
Chapter 10 COMPANY PROFILES 
ACTINIUM PHARMACEUTICALS INC. 
ADVANCED ACCELERATOR APPLICATIONS SA 
ADVANCED MEDICAL ISOTOPE CORP. 
ALLIANCE MEDICAL GROUP 
ALSERES PHARMACEUTICALS INC. 
AUSTRALIAN NUCLEAR ASSOCIATION AND TECHNOLOGY ORGANIZATION 
AYTU BIOSCIENCE INC. 
BARD MEDICAL 
BAYER PHARMA AG 
BLUE EARTH DIAGNOSTICS LTD. 
BOARD OF RADIATION AND ISOTOPE TECHNOLOGY 
BRACCO DIAGNOSTIC INC. 
BTG INTERNATIONAL LTD. 
CARDINAL HEALTH INC. 
ELI LILLY AND COMPANY 
FUJIFILM RI PHARMA CO. LTD. 
GE HEALTHCARE 
IBA MOLECULAR 
ISORAY MEDICAL INC. 
ISO-TEX DIAGNOSTICS INC. 
JUBILANT DRAXIMAGE INC. 
LANTHEUS MEDICAL IMAGING INC. 
MALLINCKRODT PLC 
NATIONAL CENTRE FOR NUCLEAR RESEARCH POLATOM 
NATIONAL INSTITUTE FOR RADIOELEMENTS (IRE) 
NAVIDEA BIOPHARMACEUTICALS INC. 
NORDION INC. 
NTP RADIOISOTOPES SOC LTD 
PHARMALUCENCE INC. 
PIRAMAL IMAGING SA 
SIEMENS HEALTHCARE GMBH 
SPECTRUM PHARMACEUTICALS INC. 
TRIAD ISOTOPES INC. 
ZEVACOR MOLECULAR 
Chapter 11 ABBREVIATIONS<\/p>\n

Buy Now @ https:\/\/www.wiseguyreports.com\/checkout?currency=one_user-USD&report_id=3375388<\/a><\/strong><\/p>\n

Continued…                       <\/strong><\/p>\n

 <\/strong><\/p>\n

Contact Us: <\/strong>Sales@Wiseguyreports.Com<\/strong><\/a> Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)<\/strong><\/p>\n

 <\/strong><\/p>\n

 <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.wiseguyreports.com\/sample-request\/3375388-radiopharmaceuticals-technologies-and-global-markets<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Radiopharmaceuticals” Wiseguyreports.Com Adds \u201cRadiopharmaceuticals -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023\u201d To Its Research Database Radiopharmaceuticals Industry Description Radiopharmaceuticals are medicinal formulations that contain radioisotopes. They are composed of a radioisotope and a carrier molecule … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-261775","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/261775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=261775"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/261775\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=261775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=261775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=261775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}